Back to results
US 2025/0352616 A1Published application
Annelid hemoglobin for use in the treatment of fuchs' disease
AssigneesHemarina, Fondation A De Rothschild
InventorsEric GABISON, Ludovic PERRAUD, Benoit SOUQUET, Damien GUINDOLET, Franck ZAL
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of at least one molecule selected from among an Annelid globin, an Annelid globin protomer and an Annelid extracellular hemoglobin for the treatment of Fuchs' disease.
Claims10
A method for treating Fuchs' corneal endothelial dystrophy in a subject, the method comprising:
- administering a molecule selected from Annelida globin, Annelida globin protomer, and Annelida extracellular hemoglobin to said subject.
Dependencies are inferred from the claim text.